Literature DB >> 22367469

A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer.

Yoo Na Kim1, Chin A Yi, Kyung Soo Lee, O Jung Kwon, Ho Yun Lee, Byung-Tae Kim, Joon Young Choi, Seon Woo Kim, Man Pyo Chung, Joungho Han, Tae Sung Kim, Myung Jin Chung, Young Mog Shim.   

Abstract

OBJECTIVES: To determine the positive reading criteria for malignant nodes when interpreting combined MRI and PET/CT images for preoperative nodal staging in non-small-cell lung cancer (NSCLC).
METHODS: Forty-nine patients with biopsy-proven NSCLC underwent both PET/CT and thoracic MRI [diffusion weighted imaging (DWI)]. Each nodal station was evaluated for the presence of metastasis by applying either inclusive (positive if either one read positive) or exclusive (positive if both read positive) criteria in the combined interpretation of PET/CT and MRI. Nodal stage was confirmed pathologically. The combined diagnostic accuracy of PET/CT and MRI was determined on per-nodal station and per-patient bases and compared with that of PET/CT alone.
RESULTS: In 49 patients, 39 (19%) of 206 nodal stations harboured malignant cells. Out of 206 nodal stations, 186 (90%) had concordant readings, while the rest (10%) had discordant readings. Inclusive criteria of combined PET/CT and MRI helped increase sensitivity for detecting nodal metastasis (69%) compared with PET/CT alone (46%; P = 0.003), while specificity was not significantly decreased.
CONCLUSION: Inclusive criteria in combined MRI and PET/CT readings help improve significantly the sensitivity for detecting nodal metastasis compared with PET/CT alone and may decrease unnecessary open thoracotomy. Key Points • Combined interpretation of MRI and PET/CT enhances the detection of nodal metastasis. • Inclusive criteria of combined MRI/PET/CT improved the sensitivity for detecting nodal metastasis. • Combined interpretation of MRI and PET/CT may reduce unnecessary open thoracotomies.

Entities:  

Mesh:

Year:  2012        PMID: 22367469     DOI: 10.1007/s00330-012-2388-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  38 in total

1.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.

Authors:  N C Gupta; G M Graeber; H A Bishop
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

2.  Multiparametric imaging of tumor response to therapy.

Authors:  Anwar R Padhani; Kenneth A Miles
Journal:  Radiology       Date:  2010-08       Impact factor: 11.105

3.  Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.

Authors:  Sung Shine Shim; Kyung Soo Lee; Byung-Tae Kim; Myung Jin Chung; Eun Jung Lee; Joungho Han; Joon Young Choi; O Jung Kwon; Young Mog Shim; Seonwoo Kim
Journal:  Radiology       Date:  2005-07-12       Impact factor: 11.105

4.  T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT.

Authors:  J M Seely; J R Mayo; R R Miller; N L Müller
Journal:  Radiology       Date:  1993-01       Impact factor: 11.105

Review 5.  A review of 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic?

Authors:  P A Bottomley; C J Hardy; R E Argersinger; G Allen-Moore
Journal:  Med Phys       Date:  1987 Jan-Feb       Impact factor: 4.071

6.  Soft-tissue masses: histologic basis for decreased signal (short T2) on T2-weighted MR images.

Authors:  M Sundaram; M H McGuire; F Schajowicz
Journal:  AJR Am J Roentgenol       Date:  1987-06       Impact factor: 3.959

7.  Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.

Authors:  Hiroaki Nomori; Takeshi Mori; Koei Ikeda; Koichi Kawanaka; Shinya Shiraishi; Kazuhiro Katahira; Yasuyuki Yamashita
Journal:  J Thorac Cardiovasc Surg       Date:  2008-04       Impact factor: 5.209

8.  Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography.

Authors:  W J Scott; L S Gobar; J D Terry; N A Dewan; J J Sunderland
Journal:  J Thorac Cardiovasc Surg       Date:  1996-03       Impact factor: 5.209

Review 9.  Noninvasive staging of non-small cell lung cancer: a review of the current evidence.

Authors:  Eric M Toloza; Linda Harpole; Douglas C McCrory
Journal:  Chest       Date:  2003-01       Impact factor: 9.410

10.  Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging.

Authors:  Yoshiharu Ohno; Hiroto Hatabu; Daisuke Takenaka; Takanori Higashino; Hirokazu Watanabe; Chiho Ohbayashi; Masahiro Yoshimura; Miyako Satouchi; Yoshihiro Nishimura; Kazuro Sugimura
Journal:  Radiology       Date:  2004-06       Impact factor: 11.105

View more
  9 in total

1.  Surgery following neoadjuvant chemotherapy for non-small-cell lung cancer patients with unexpected persistent pathological N2 disease.

Authors:  Xue-Fei Hu; Liang Duan; Ge-Ning Jiang; Chang Chen; K E Fei
Journal:  Mol Clin Oncol       Date:  2015-12-11

2.  Preoperative staging of non-small cell lung cancer: prospective comparison of PET/MR and PET/CT.

Authors:  Sang Min Lee; Jin Mo Goo; Chang Min Park; Soon Ho Yoon; Jin Chul Paeng; Gi Jeong Cheon; Young Tae Kim; Young Sik Park
Journal:  Eur Radiol       Date:  2016-02-16       Impact factor: 5.315

Review 3.  Magnetic resonance imaging for N staging in non-small cell lung cancer: A systematic review and meta-analysis.

Authors:  Yuanyuan Zhang; Qin Qin; Baosheng Li; Juan Wang; Kun Zhang
Journal:  Thorac Cancer       Date:  2015-01-08       Impact factor: 3.500

4.  Diffusion-weighted magnetic resonance imaging for the detection of metastatic lymph nodes in patients with lung cancer: A meta-analysis.

Authors:  Guang-Xiang Chen; Mao-Hua Wang; Ting Zheng; Guang-Cai Tang; Fu-Gang Han; Guo-Jian Tu
Journal:  Mol Clin Oncol       Date:  2017-02-06

5.  Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.

Authors:  Guohua Shen; You Lan; Kan Zhang; Pengwei Ren; Zhiyun Jia
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

Review 6.  Functional imaging in lung cancer.

Authors:  S W Harders; S Balyasnikowa; B M Fischer
Journal:  Clin Physiol Funct Imaging       Date:  2013-12-01       Impact factor: 2.273

7.  Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.

Authors:  Won Hwa Kim; Sang-Woo Lee; Hye Jung Kim; Yee Soo Chae; Shin Young Jeong; Jin Hyang Jung; Ho Yong Park; Won Kee Lee
Journal:  Sci Rep       Date:  2018-02-16       Impact factor: 4.379

8.  A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT.

Authors:  Kyoungjune Pak; Keunyoung Kim; Mi-Hyun Kim; Jung Seop Eom; Min Ki Lee; Jeong Su Cho; Yun Seong Kim; Bum Soo Kim; Seong Jang Kim; In Joo Kim
Journal:  PLoS One       Date:  2018-02-27       Impact factor: 3.240

9.  Diagnostic value and clinical significance of MRI and CT in detecting lymph node metastasis of early cervical cancer.

Authors:  Lan Luo; Qian Luo; Liang Tang
Journal:  Oncol Lett       Date:  2019-12-04       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.